FDA Inspection 1252039 — Wuhan Zonsen Medical Products Co., Ltd
The FDA completed an inspection of Wuhan Zonsen Medical Products Co., Ltd on Jul 26, 2024 in Wuhan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wuhan (China)